Indivior (INDV) Share Price

Health Care Sector

  1. Home
    2. /
  2. Company
    3. /
  3. Indivior

NOTE: This is based on 99 open tips for Indivior (INDV)


Indivior (INDV)
Latest Quote Price

968.00p

Indivior (INDV)
Price Change (%)

1.48%


Latest Bid : 960.50p Latest Ask : 962.00p
High Today : 978.00p Low Today : 937.50p
This Years High : 1,764.00p This Years Low : 576.50p
Volume : 94,144 MKT Cap : £1210M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only

Indivior (INDV) Overview

Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.

Indivior (INDV) Latest Tips

Type Tipster SectorScore Start date Performance
Buy Jefferies Premium Only 2024-12-17 16:02:00 17/12/2024 3.86%
Buy Deutsche Bank Premium Only 2024-10-11 07:15:00 11/10/2024 66.47%
Buy Deutsche Bank Premium Only 2024-09-05 13:16:00 05/09/2024 2.81%
Buy Jefferies Premium Only 2024-08-09 12:20:00 09/08/2024 -2.27%
Buy Deutsche Bank Premium Only 2024-07-10 07:19:00 10/07/2024 23.23%

Premium Content

You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


Indivior (INDV) Active Short Positions

Fund Manager Position Date
Arrowstreet Capital, Limited Partnership 0.6% 26/11/2024
Qube Research & Technologies Limited 1.4% 25/11/2024
Numeric Investors LLC 0.71% 14/11/2024
Point72 Asset Management, L.P. 0.76% 14/10/2024
AHL Partners LLP 0.58% 31/07/2024

See more short positions...


Latest Bid : 960.50p Latest Ask : 962.00p
High Today : 978.00p Low Today : 937.50p
This Years High : 1,764.00p This Years Low : 576.50p
Volume : 94,144 MKT Cap : £1210M

Indivior Overview

Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Latest Indivior Tips

Type Tipster SectorScore Start date Performance
Buy Jefferies Premium Only 2024-12-17 16:02:00 17/12/2024 3.86%
Buy Deutsche Bank Premium Only 2024-10-11 07:15:00 11/10/2024 66.47%
Buy Deutsche Bank Premium Only 2024-09-05 13:16:00 05/09/2024 2.81%
Buy Jefferies Premium Only 2024-08-09 12:20:00 09/08/2024 -2.27%
Buy Deutsche Bank Premium Only 2024-07-10 07:19:00 10/07/2024 23.23%